Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Hematopoietic Stem Cell Transplantation: early-phase trial registry
14 of 27 indexed Hematopoietic Stem Cell Transplantation trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #598 of 28,707 conditions by registered trial count.
27 US clinical trials · 14 currently recruiting · #598 of 28,707 conditions by registered trial count
Hematopoietic Stem Cell Transplantation: 27 US clinical trials tracked, 14 recruiting.
Hematopoietic Stem Cell Transplantation is the subject of 27 registered US clinical trials on ClinicalTrials.gov, 14 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 10 in Phase 1-2 (earlier-stage). The most active sponsor is National Cancer Institute (NCI), running 4 of these trials.
Enrollment posture brief
Registry condition hematopoietic-stem-cell-transplantation
OPEN 14 | RECR 52% | LATE 0 | EARLY 10 | RANK #598 | SPON 4
Volume-matched condition peers
Nearest open-share peer: Aortic Stenosis (52% recruiting · 27 trials)
Hematopoietic Stem Cell Transplantation lists 14 open slots (52% of 27 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Hematopoietic Stem Cell Transplantation on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Hematopoietic Stem Cell Transplantation is recruiting above its size-band peers.
14 of 27 indexed trials (51.9%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Hematopoietic Stem Cell Transplantation trials is spread across many organizations.
National Cancer Institute (NCI) accounts for 4 of 27 trials (14.8%). 20 distinct sponsors appear on at least one study for this condition label.
-
Most Hematopoietic Stem Cell Transplantation trials plan to enrol fewer than 100 people.
Median target enrolment is 54 among the 27 trials that report a genuine target (sentinel values excluded). 17 of those (63%) plan for fewer than 100 participants.
-
Hematopoietic Stem Cell Transplantation research is mostly interventional.
19 interventional and 8 observational studies make up this index (70.4% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
27 total, page 1 of 1
The Collection and Storage of Umbilical Cord Blood for Transplantation
M.D. Anderson Cancer Center
NCT01728545
Long-Term Follow-up of People Undergoing Hematopoietic Stem Cell Transplantation
National Cancer Institute (NCI)
NCT03000244
The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation
National Cancer Institute (NCI)
NCT05436418
Longitudinal Early Advance Care Planning Discussions and Documentation (LEADD) Program: An Exploratory Study in Adolescents and Young Adults (AYAs) Receiving Hematopoietic Stem Cell Transplant
National Cancer Institute (NCI)
NCT05605574
Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients
University of Michigan Rogel Cancer Center
NCT02763033
Supportive Care Intervention for Outpatient Stem Cell Transplant Patients
Victor Wang
NCT06564233
Cultural Tailoring and Pilot Testing of an Inpatient Yoga Therapy Program for Cancer Patients Undergoing Hematopoietic Stem Cell Transplantation in India, Tanzania, and the United States
M.D. Anderson Cancer Center
NCT05681026
A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome
National Cancer Institute (NCI)
NCT05027945
αβT Cell/CD19+ B Cell Depletion for Alternative Donor Allogeneic Hematopoietic Cell Transplantation (HSCT)
Nationwide Children's Hospital
NCT06082947
Employment Support After Hematopoietic Stem Cell Transplantation
MGH Institute of Health Professions
NCT06494423
Metagenomics Next-generation Sequencing Approach to Detect Microbial DNA/RNA Overtime in Individuals Undergoing Hematopoietic Stem Cell Transplant
National Institutes of Health Clinical Center (CC)
NCT06904053
Prevention of Graft Rejection in Hematopoietic Stem Cell Transplant (HSCT) Recipients
Children's Hospital Medical Center, Cincinnati
NCT07244419
Zoledronate to Prevent Bone Health Complications in Pediatric Hematopoietic Stem Cell Transplant Survivors
Children's Hospital Medical Center, Cincinnati
NCT07375290
Efficacy and Safety Study of Narsoplimab in Pediatric Patients With High-Risk Hematopoietic Stem Cell Transplant TMA
Omeros Corporation
NCT05855083
Multimodal Sexual Dysfunction Intervention In HCT
Massachusetts General Hospital
NCT03803696
Standardization of CD3+ T Cell Dose for Patients Receiving Allogeneic Peripheral Blood Stem Cell Transplantation From Matched Related Donors
University of Alabama at Birmingham
NCT00959140
Art and Physical Therapy in Pediatric HCT
Medical University of South Carolina
NCT05441670
Protocol For Collecting Long-Term Follow-Up Data On Recipients of Bone Marrow and Blood Stem Cell Transplant
St. Jude Children's Research Hospital
NCT00674882
Problem-Solving Education for Caregivers and Patients During Stem Cell Transplant
National Institutes of Health Clinical Center (CC)
NCT00766883
Iron Overload in Patients Undergoing Donor Stem Cell Transplant
Masonic Cancer Center, University of Minnesota
NCT00888316
Evaluation of Immunoregulatory Cells in Hematopoietic Stem Cell Transplant
Vanderbilt University
NCT00179049
High Dose Intravenous Thiamine for the Prevention of Delirium in Allogeneic Hematopoietic Stem Cell Transplantation
UNC Lineberger Comprehensive Cancer Center
NCT03263442
Treating Cancer-Related Fatigue Through Systematic Light Exposure
Icahn School of Medicine at Mount Sinai
NCT01873794
Comparison of Gut Microbiota, Inflammation and Symptoms Following Allogeneic HSCT
University of Florida
NCT02398708
Cord Blood Transplantation for Sickle Cell Anemia and Thalassemia
National Heart, Lung, and Blood Institute (NHLBI)
NCT00029380
Evaluation of Malglycemia Via Continuous Glucose Monitoring in the Pediatric HSCT Population
University of Colorado, Denver
NCT03037671
Dose Escalation Study Of Palifermin in Pediatric Research Participants Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
St. Jude Children's Research Hospital
NCT00701688
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 4 |
| Phase 2 | 6 |
Top Sponsors
Named interventions
Most-linked intervention names on Hematopoietic Stem Cell Transplantation records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Hematopoietic Stem Cell Transplantation trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Hematopoietic Stem Cell Transplantation page
27 registered trials, 14 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 14 Hematopoietic Stem Cell Transplantation trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- National Cancer Institute (NCI) sponsors the most Hematopoietic Stem Cell Transplantation trials on record, review their full trial history before evaluating a specific study. See National Cancer Institute (NCI)'s trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Hematopoietic Stem Cell Transplantation condition card totals 27 registered trials; most-linked intervention Busulfan; top US site state Maryland. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.